1. Hepatitis C Virus of Subtype 2l in Marseille, Southeastern France.
- Author
-
aherfi, Sarah, Glazunova, Olga, Borentain, Patrick, Botta-Fridlund, Daniele, Chiche, Laurent, Bregigeon, Sylvie, Motte, anne, Tamalet, Catherine, and Colson, Philippe
- Subjects
- *
HEPATITIS C treatment , *ANTIVIRAL agents , *NUCLEOTIDE sequence , *MEDICAL microbiology , *HEPATITIS C , *PATIENTS - Abstract
The rate of eradication of chronic hepatitis C considerably increases with direct-acting antiviral agents, particularly hepatitis C virus (HCV) polymerase inhibitors. While implementing full-length HCV NS5B polymerase sequencing in our clinical microbiology laboratory, we identified atypical HCV sequences, classified as subtype 2l, from 2 patients. HCV-2l NS5B polymerase sequences were detected from 5 and 14 additional patients by screening our laboratory hepatitis virus sequence database and the NCBI GenBank sequence database. Phylogenetic analyses show unambiguously that all HCV-2l sequences are clustered apart from HCV 2 non-l sequences, which compose a second cluster. Mean (±SD) nucleotide identity between near full-length NS5B fragments of subtype 2l was 93.4 ± 0.8% (range: 92.4-95.1). Of note, all HCV-2l sequences obtained in our laboratory and in other centers were from serum samples collected in France. Analysis of the HCV-2l NS5B polymerase amino acid sequences at 30 positions critical for interaction with or resistance to HCV polymerase inhibitors showed specific patterns. © 2015 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF